Cargando…
1440. Local Antibiogram for Mycobacterium abscessus Shows Variability from Previously Published Susceptibility Data
BACKGROUND: Mycobacterium abscessus complex (MabsC) causes a wide variety of human disease and is frequently resistant to multiple agents. Empiric therapy is typically based on previously published susceptibility data which suggests amikacin (AMK), cefoxitin (FOX), clarithromycin (CLR), and imipenem...
Autores principales: | McElroy, Timothy, Starlin, Richard, Van Schooneveld, Trevor C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752831/ http://dx.doi.org/10.1093/ofid/ofac492.1269 |
Ejemplares similares
-
In Vitro Antimicrobial Susceptibility of Mycobacterium abscessus in Korea
por: Park, Sunghoon, et al.
Publicado: (2008) -
Vancomycin and Clarithromycin Show Synergy against Mycobacterium abscessus In Vitro
por: Mukherjee, Devika, et al.
Publicado: (2017) -
Teicoplanin – Tigecycline Combination Shows Synergy Against Mycobacterium abscessus
por: Aziz, Dinah B., et al.
Publicado: (2018) -
In Vitro Susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum Isolates to 30 Antibiotics
por: Shen, Yaojie, et al.
Publicado: (2018) -
Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)